Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities
β Scribed by Renata Mikstacka; Wanda Baer-Dubowska; Marcin Wieczorek; Stanislaw Sobiak
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 923 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1613-4125
No coin nor oath required. For personal study only.
β¦ Synopsis
Resveratrol (3,5,49-trihydroxy-trans-stilbene) is a natural stilbene derivative occurring in grapes, peanuts and red wine. Its chemopreventive action has been established in studies on animal models. Recently, numerous classes of compounds with stilbene backbone have been investigated for their biological activity concerning cancer prevention; e. g. resveratrol methyl ethers appeared to be specific and potent inhibitors of cytochromes P450 (CYP) family 1 involved in the activation of procarcinogens. Since the replacement of the 49-hydroxyl with a thiomethyl group is supposed to reduce toxicity of stilbene derivatives, the purpose of this study was the synthesis and evaluation of a series of 4-thiomethyl-trans-stilbene derivatives differing in a number and position of additional methoxy groups. Their inhibitory potency toward human recombinant CYPs: CYP1A1, CYP1A2 and CYP1B1 have been studied and compared with the effect of resveratrol and its analogues. Among compounds tested, 2-methoxy-49-thiomethyl-trans-stilbene and 3-methoxy-49-thiomethyl-trans-stilbene demonstrated the most potent and selective inhibitory effect on CYP1A1 and CYP1B1 activities. The results of our study indicate that modification of stilbene derivatives with thiomethyl group may influence the selectivity and inhibitory potency of these compounds toward P450 isozymes. Thus, it should be considered in developing new chemopreventive agents based on their mechanism of action.
π SIMILAR VOLUMES
## Abstract CYP1A1 and CYP1A2 enzymes metabolize polycyclic aromatic hydrocarbons (PAHs) to the reactive oxyderivatives. PAHs can induce the activity of both enzymes, which increases its conversion and enhances risk of carcinogenesis. Thus, the inhibition of CYP enzymes is recognized as a cancer ch
## Abstract We report a comprehensive examination of rat hepatic CYP1A2 and CYP2E1 ontogeny. We compare the data to human data to determine the rat's capacity as a model to identify CYPβmediated mechanisms underlying ageβdependent differences in susceptibility to toxicity. We evaluated CYP expressi